Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04196595 · ClinicalTrials.gov registry record
Apple Women's Health Study
A clinical trial of Infertility and Menopause, sponsored by Apple.
- Recruiting
- Registry status
- 500,000
- Enrollment target
- 1
- Study location
NCT04196595: Recruiting study of Infertility and Menopause, sponsored by Apple.
NCT04196595 is a study of Infertility and Menopause that is actively recruiting participants, run by Apple. The registered enrollment target is 500,000 participants, above the 833-participant average among 74 other Infertility trials with a reported enrollment target (59924% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04196595, a study of Infertility and Menopause, is actively recruiting participants, sponsored by Apple.
- RECRUITING
- Registry status
- 500,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational longitudinal study to advance the understanding of menstrual cycle and gynecologic health conditions including PCOS, infertility and breast cancer.The study will be hosted within the Research app(available on App Store), which allows a user to find, enroll, and participate in Apple-supported health-related research studies.
Primary Outcome
Characterized using duration of menstrual flow, and cycle length in unit of days.
Conditions Studied
Study Locations (1)
Massachusetts
- Harvard T.H. Chan School of Public Health - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500,000 participants |
| Start Date | 2019-11-14 |
| Est. Completion | 2029-11 |
What NCT04196595 shows while recruiting
NCT04196595 is an observational study that tracks outcomes without assigning an intervention. Its 500,000 participants enrollment target places it among the larger protocols in the corpus, above the 833-participant average among 74 other Infertility trials with a reported enrollment target (59924% higher).
The record links to 8 conditions, with Infertility appearing as the primary indexed condition, and to 0 interventions.
NCT04196595 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04196595 about?
NCT04196595 is a clinical study titled "Apple Women's Health Study". This is an observational longitudinal study to advance the understanding of menstrual cycle and gynecologic health conditions including PCOS, infertility and breast cancer.The study will be hosted within the Research app(available on App Store), which allows a user to find, enroll, and participate i...
What is the current status of trial NCT04196595?
This trial is currently recruiting. The enrollment target is 500,000 participants. The study started on 2019-11-14. Estimated completion is 2029-11.
What conditions does trial NCT04196595 study?
This clinical trial studies the following conditions: Infertility, Menopause, Polycystic Ovary Syndrome, Reproductive Health, Menstrual Cycle.
Who is sponsoring clinical trial NCT04196595?
This trial is sponsored by Apple, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04196595 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04196595's enrollment target sits among peer trials
500,000 1st of 74 higher than 74 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
RECRUITING · Phase 1
-
Non-Euploid Embryo Transfer (NEET) Registry
RECRUITING
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Discarded Materials Study
RECRUITING
-
Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05065060 · 500,000 participants
Parkinson Progression Marker Initiative Online (PPMI Online)
- NCT06017687 · 500,000 participants · NA
Data Collection and Evaluation of OptiBP Under Investigational Use
- NCT06342375 · 425,000 participants · NA
Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage
- NCT06934239 · 400,000 participants · Phase 4
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI